Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
This study has been completed.
Association Française contre les Myopathies (AFM), Paris
Information provided by (Responsible Party):
First received: February 18, 2011
Last updated: October 18, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2013|
|Primary Completion Date:||October 2013 (Final data collection date for primary outcome measure)|